The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility… read more
-
ETF
Equity
- years
51 holdings
$27.57
Price+0.79%
$0.22
$14.328m
Small
$5.543k
Avg Volume$18.342m
$28.21
NAV0.60%
Expense Ratio1.31%
Yield$0.36
Dividend